Claytons research contributions to PT-141 development include: Principal investigator for pivotal Phase 2 dose-finding trial establishing optimal 1.75 mg dose Lead investigator for RECONNECT Phase 3 trials supporting FDA approval Development of responder analysis methodology for patient-reported outcomes in sexual dysfunction Neurobehavioral research elucidating central mechanisms of sexual desire Extensive publication record on bremelanotide efficacy, safety, and clinical applications Her work has established PT-141 as the second FDA-approved pharmacological treatment for HSDD and the first melanocortin-based therapy for sexual dysfunction, representing a significant advance in womens sexual health treatment options
This benefit is backed by EWGs assessment, which highlights glutathiones function in skin conditioning without high-risk concerns
doi:10.1016/0014-5793(87)81495-3
In medical terms, a balanced GLP-1 system means the body produces adequate amounts of this hormone in response to nutrient intake, and that the hormone functions effectively at its target receptors throughout the body
This study is of particular interest because the researchers also paired gene studies with laboratory studies, confirming that changes in gene expression are associated with improved collagen reorganization and fibroblasts function [ 28 ] Further studies confirmed the ability of GHK-Cu to reverse gene expression in COPD back to health [ 29 ]
In addition to these five biggest benefits, there are also other benefits, just as important to some people: They're great for your teeth and bones
